The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs provide access to funds to develop innovations with potential commercial applications.
Over $2.5 billion is invested annually in these highly competitive awards-based programs in order to support scientific excellence, foster technological innovation, and help bridge the gap between performance of basic science and commercialization of resulting innovations.
On June 23rd, join the Penn State Center for Medical Innovation and our distinguished panel as we explore the following topics:
Charles Smith, PhD
President & CEO Apogee Biotechnology Corporation; SBIR recipient of over $14 million to date to develop orally available, small molecules for the treatment of cancer and inflammatory diseases
Jeffrey Neighbors, PhD
Penn State College of Medicine Assistant Professor of Pharmacology; SBIR/STTR recipient phase I and II, and acting consultant for companies resulting in successful submissions to DOD, NIH and USDA
Colin Barnstable, DPhil
Penn State College of Medicine Chair and Professor of Neural & Behavioral Sciences Department; served for three years on the SBIR study section dealing with vision and hearing, then was the chair for an additional two years
Kelly Wylam, MA
Innovation Partnership (IPart) Director;assists early stage technology companies, entrepreneurs, and small technology companies in securing SBIR/STTR and other federal funding opportunities
Mel Billingsley, PhD
President & CEO Life Science Greenhouse, Penn State College of Medicine Professor of Pharmacology, and Penn State Harrisburg Professor of Biotechnology and Entrepreneurship; background includes rich and varied experience as a researcher, educator and investor, as well as a long history of actively fostering the advancement of technology within the larger community
P.O. Box 83 Boiling Springs, PA 17007